Brivaracetam for spinal cord injury–related neuropathic pain: results of a pilot double-blinded, randomized, placebo-controlled clinical trial
These findings suggest safety, tolerability, and feasibility of brivaracetam for treating neuropathic pain in spinal cord injury. These pilot findings will be used to power future efficacy clinical trials.
Authors
- Nguyen Nguyen
- Clas Linnman (ORCID: https://orcid.org/0000-0001-8449-894X)
- B.G. deVries
- Robert Wudlick (ORCID: https://orcid.org/0000-0001-6021-1238)
- Abigail Welch (ORCID: https://orcid.org/0000-0002-1269-4527)
- Scott Falci (ORCID: https://orcid.org/0000-0003-4209-0959)
- Richard Goldstein (ORCID: https://orcid.org/0000-0002-1100-9452)
- Ricardo A. Battaglino (ORCID: https://orcid.org/0000-0002-0272-1763)
- Leslie R. Morse (ORCID: https://orcid.org/0000-0002-7426-6341)
- Michael Stillman (ORCID: https://orcid.org/0000-0002-1937-3742)
- Grant Anderton
- Joda Glossner
- Ana Lucia Battaglino
Institutions
- Craig Hospital (US)
- Harvard University (US)
- University of Miami (US)
- Thomas Jefferson University (US)
- Spaulding Rehabilitation Hospital (US)
- Swedish Medical Center (US)
- University of Minnesota Medical Center (US)
Publication Details
- Journal
- PAIN Reports
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1097/pr9.0000000000001301
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Craig H. Neilsen Foundation